InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Valente Nancy. Officer active across 2 companies, notably Myovant Sciences Ltd.. In total, 7 reports have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €181k. History available since 26 October 2022. The latest transaction was filed on 2 May 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Valente Nancy is a declarant linked to Xencor Inc, where she is EVP, Chief Development Officer, and to Myovant Sciences Ltd., where she is Director. She has 7 filings in total, and among the 7 sampled filings the sales amount to EUR 181415 between 2022-10-28 and 2025-05-06, with Cession as the most frequent transaction nature.